Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
The CDKN2A(p16) gene plays a key role in pancreatic cancer etiology. It is one of the most commonly somatically mutated genes in pancreatic cancer, rare germline mutations have been found to be associated with increased risk of developing familiar pancreatic cancer and CDKN2A promoter hyper-methylat...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Impact Journals
2016
|
| _version_ | 1797102640498212864 |
|---|---|
| author | Campa, D Pastore, M Gentiluomo, M Talar-Wojnarowska, R Kupcinskas, J Malecka-Panas, E Neoptolemos, J Niesen, W Vodicka, P Delle Fave, G Bas Bueno-de-Mesquita, H Gazouli, M Pacetti, P Di Leo, M Ito, H Klüter, H Soucek, P Corbo, V Yamao, K Hosono, S Kaaks, R Vashist, Y Gioffreda, D Strobel, O Shimizu, Y Dijk, F Andriulli, A Ivanauskas, A Bugert, P Tavano, F Vodickova, L Federico Zambon, C Lovecek, M Landi, S Key, T Boggi, U Pezzilli, R Jamroziak, K Mohelnikova-Duchonova, B Mambrini, A Bambi, F Busch, O Pazienza, V Valente, R Theodoropoulos, G Hackert, T Capurso, G Martina Cavestro, G Pasquali, C Basso, D Sperti, C Matsuo, K Büchler, M Khaw, K Izbicki, J Costello, E Katzke, V Michalski, C Stepien, A Rizzato, C Canzian, F |
| author_facet | Campa, D Pastore, M Gentiluomo, M Talar-Wojnarowska, R Kupcinskas, J Malecka-Panas, E Neoptolemos, J Niesen, W Vodicka, P Delle Fave, G Bas Bueno-de-Mesquita, H Gazouli, M Pacetti, P Di Leo, M Ito, H Klüter, H Soucek, P Corbo, V Yamao, K Hosono, S Kaaks, R Vashist, Y Gioffreda, D Strobel, O Shimizu, Y Dijk, F Andriulli, A Ivanauskas, A Bugert, P Tavano, F Vodickova, L Federico Zambon, C Lovecek, M Landi, S Key, T Boggi, U Pezzilli, R Jamroziak, K Mohelnikova-Duchonova, B Mambrini, A Bambi, F Busch, O Pazienza, V Valente, R Theodoropoulos, G Hackert, T Capurso, G Martina Cavestro, G Pasquali, C Basso, D Sperti, C Matsuo, K Büchler, M Khaw, K Izbicki, J Costello, E Katzke, V Michalski, C Stepien, A Rizzato, C Canzian, F |
| author_sort | Campa, D |
| collection | OXFORD |
| description | The CDKN2A(p16) gene plays a key role in pancreatic cancer etiology. It is one of the most commonly somatically mutated genes in pancreatic cancer, rare germline mutations have been found to be associated with increased risk of developing familiar pancreatic cancer and CDKN2A promoter hyper-methylation has been suggested to play a critical role both in pancreatic cancer onset and prognosis. In addition several unrelated SNPs in the 9p21.3 region, that includes the CDNK2A, CDNK2B and the CDNK2B-AS1 genes, are associated with the development of cancer in various organs. However, association between the common genetic variability in this region and pancreatic cancer risk is not clearly understood. We sought to fill this gap in a case-control study genotyping 13 single nucleotide polymorphisms (SNPs) in 2,857 pancreatic ductal adenocarcinoma (PDAC) patients and 6,111 controls in the context of the Pancreatic Disease Research (PANDoRA) consortium. We found that the A allele of the rs3217992 SNP was associated with an increased pancreatic cancer risk (OR het=1.14, 95% CI 1.01-1.27, p=0.026, ORhom =1.30, 95% CI 1.12-1.51, p=0.00049). This pleiotropic variant is reported to be a mir-SNP that, by changing the binding site of one or more miRNAs, could influence the normal cell cycle progression and in turn increase PDAC risk. In conclusion, we observed a novel association in a pleiotropic region that has been found to be of key relevance in the susceptibility to various types of cancer and diabetes suggesting that the CDKN2A/Blocus could represent a genetic link between diabetes and pancreatic cancer risk. |
| first_indexed | 2024-03-07T06:08:49Z |
| format | Journal article |
| id | oxford-uuid:eec284e3-c694-4ed0-bfd4-fb7fd62a1872 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:08:49Z |
| publishDate | 2016 |
| publisher | Impact Journals |
| record_format | dspace |
| spelling | oxford-uuid:eec284e3-c694-4ed0-bfd4-fb7fd62a18722022-03-27T11:35:28ZFunctional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:eec284e3-c694-4ed0-bfd4-fb7fd62a1872EnglishSymplectic Elements at OxfordImpact Journals2016Campa, DPastore, MGentiluomo, MTalar-Wojnarowska, RKupcinskas, JMalecka-Panas, ENeoptolemos, JNiesen, WVodicka, PDelle Fave, GBas Bueno-de-Mesquita, HGazouli, MPacetti, PDi Leo, MIto, HKlüter, HSoucek, PCorbo, VYamao, KHosono, SKaaks, RVashist, YGioffreda, DStrobel, OShimizu, YDijk, FAndriulli, AIvanauskas, ABugert, PTavano, FVodickova, LFederico Zambon, CLovecek, MLandi, SKey, TBoggi, UPezzilli, RJamroziak, KMohelnikova-Duchonova, BMambrini, ABambi, FBusch, OPazienza, VValente, RTheodoropoulos, GHackert, TCapurso, GMartina Cavestro, GPasquali, CBasso, DSperti, CMatsuo, KBüchler, MKhaw, KIzbicki, JCostello, EKatzke, VMichalski, CStepien, ARizzato, CCanzian, FThe CDKN2A(p16) gene plays a key role in pancreatic cancer etiology. It is one of the most commonly somatically mutated genes in pancreatic cancer, rare germline mutations have been found to be associated with increased risk of developing familiar pancreatic cancer and CDKN2A promoter hyper-methylation has been suggested to play a critical role both in pancreatic cancer onset and prognosis. In addition several unrelated SNPs in the 9p21.3 region, that includes the CDNK2A, CDNK2B and the CDNK2B-AS1 genes, are associated with the development of cancer in various organs. However, association between the common genetic variability in this region and pancreatic cancer risk is not clearly understood. We sought to fill this gap in a case-control study genotyping 13 single nucleotide polymorphisms (SNPs) in 2,857 pancreatic ductal adenocarcinoma (PDAC) patients and 6,111 controls in the context of the Pancreatic Disease Research (PANDoRA) consortium. We found that the A allele of the rs3217992 SNP was associated with an increased pancreatic cancer risk (OR het=1.14, 95% CI 1.01-1.27, p=0.026, ORhom =1.30, 95% CI 1.12-1.51, p=0.00049). This pleiotropic variant is reported to be a mir-SNP that, by changing the binding site of one or more miRNAs, could influence the normal cell cycle progression and in turn increase PDAC risk. In conclusion, we observed a novel association in a pleiotropic region that has been found to be of key relevance in the susceptibility to various types of cancer and diabetes suggesting that the CDKN2A/Blocus could represent a genetic link between diabetes and pancreatic cancer risk. |
| spellingShingle | Campa, D Pastore, M Gentiluomo, M Talar-Wojnarowska, R Kupcinskas, J Malecka-Panas, E Neoptolemos, J Niesen, W Vodicka, P Delle Fave, G Bas Bueno-de-Mesquita, H Gazouli, M Pacetti, P Di Leo, M Ito, H Klüter, H Soucek, P Corbo, V Yamao, K Hosono, S Kaaks, R Vashist, Y Gioffreda, D Strobel, O Shimizu, Y Dijk, F Andriulli, A Ivanauskas, A Bugert, P Tavano, F Vodickova, L Federico Zambon, C Lovecek, M Landi, S Key, T Boggi, U Pezzilli, R Jamroziak, K Mohelnikova-Duchonova, B Mambrini, A Bambi, F Busch, O Pazienza, V Valente, R Theodoropoulos, G Hackert, T Capurso, G Martina Cavestro, G Pasquali, C Basso, D Sperti, C Matsuo, K Büchler, M Khaw, K Izbicki, J Costello, E Katzke, V Michalski, C Stepien, A Rizzato, C Canzian, F Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. |
| title | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. |
| title_full | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. |
| title_fullStr | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. |
| title_full_unstemmed | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. |
| title_short | Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. |
| title_sort | functional single nucleotide polymorphisms within the cyclin dependent kinase inhibitor 2a 2b region affect pancreatic cancer risk |
| work_keys_str_mv | AT campad functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT pastorem functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT gentiluomom functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT talarwojnarowskar functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT kupcinskasj functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT maleckapanase functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT neoptolemosj functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT niesenw functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT vodickap functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT dellefaveg functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT basbuenodemesquitah functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT gazoulim functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT pacettip functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT dileom functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT itoh functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT kluterh functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT soucekp functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT corbov functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT yamaok functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT hosonos functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT kaaksr functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT vashisty functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT gioffredad functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT strobelo functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT shimizuy functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT dijkf functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT andriullia functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT ivanauskasa functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT bugertp functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT tavanof functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT vodickoval functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT federicozambonc functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT lovecekm functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT landis functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT keyt functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT boggiu functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT pezzillir functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT jamroziakk functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT mohelnikovaduchonovab functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT mambrinia functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT bambif functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT buscho functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT pazienzav functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT valenter functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT theodoropoulosg functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT hackertt functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT capursog functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT martinacavestrog functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT pasqualic functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT bassod functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT spertic functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT matsuok functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT buchlerm functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT khawk functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT izbickij functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT costelloe functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT katzkev functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT michalskic functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT stepiena functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT rizzatoc functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk AT canzianf functionalsinglenucleotidepolymorphismswithinthecyclindependentkinaseinhibitor2a2bregionaffectpancreaticcancerrisk |